These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25572297)

  • 1. CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target.
    de Lourdes Perim A; Amarante MK; Guembarovski RL; de Oliveira CE; Watanabe MA
    Cell Mol Life Sci; 2015 May; 72(9):1715-23. PubMed ID: 25572297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
    Juarez J; Dela Pena A; Baraz R; Hewson J; Khoo M; Cisterne A; Fricker S; Fujii N; Bradstock KF; Bendall LJ
    Leukemia; 2007 Jun; 21(6):1249-57. PubMed ID: 17410186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
    Peled A; Klein S; Beider K; Burger JA; Abraham M
    Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting chemokines for acute lymphoblastic leukemia therapy.
    Hong Z; Wei Z; Xie T; Fu L; Sun J; Zhou F; Jamal M; Zhang Q; Shao L
    J Hematol Oncol; 2021 Mar; 14(1):48. PubMed ID: 33743810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
    van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML
    Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
    Crazzolara R; Kreczy A; Mann G; Heitger A; Eibl G; Fink FM; Möhle R; Meister B
    Br J Haematol; 2001 Dec; 115(3):545-53. PubMed ID: 11736934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
    Juarez J; Bradstock KF; Gottlieb DJ; Bendall LJ
    Leukemia; 2003 Jul; 17(7):1294-300. PubMed ID: 12835717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
    Zhou Y; Cao HB; Li WJ; Zhao L
    Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression and clinical significance of stromal cell-derived factor-1 and CXCR4 in acute leukemia and malignant lymphoma].
    Zeng DF; Kong PY; Chen XH; Wei L; Chang C; Peng XG
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):522-4. PubMed ID: 16080846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.
    Ando N; Furuichi Y; Kasai S; Tamai M; Harama D; Kagami K; Abe M; Goi K; Inukai T; Sugita K
    Leuk Res; 2018 Dec; 75():36-44. PubMed ID: 30453100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4.
    Nagasawa T
    J Mol Med (Berl); 2014 May; 92(5):433-9. PubMed ID: 24722947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML.
    Sison EA; McIntyre E; Magoon D; Brown P
    Mol Cancer Res; 2013 Sep; 11(9):1004-16. PubMed ID: 23754844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis.
    Kato I; Niwa A; Heike T; Fujino H; Saito MK; Umeda K; Hiramatsu H; Ito M; Morita M; Nishinaka Y; Adachi S; Ishikawa F; Nakahata T
    PLoS One; 2011; 6(11):e27042. PubMed ID: 22069486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
    Sison EA; Magoon D; Li L; Annesley CE; Rau RE; Small D; Brown P
    Oncotarget; 2014 Oct; 5(19):8947-58. PubMed ID: 25333254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis.
    de Rooij B; Polak R; van den Berk LCJ; Stalpers F; Pieters R; den Boer ML
    Haematologica; 2017 Oct; 102(10):e389-e393. PubMed ID: 28619846
    [No Abstract]   [Full Text] [Related]  

  • 18. The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies.
    Mehrpouri M
    Eur J Pharmacol; 2022 Apr; 920():174831. PubMed ID: 35183534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CXCR4 in the progression and therapy of acute leukaemia.
    Su L; Hu Z; Yang YG
    Cell Prolif; 2021 Jul; 54(7):e13076. PubMed ID: 34050566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.
    Wang Z; Sun J; Feng Y; Tian X; Wang B; Zhou Y
    Tumour Biol; 2016 Jul; 37(7):8515-28. PubMed ID: 27079871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.